Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...

A woman from Ellsworth is navigating life with a rare neuromuscular disease. Tina Bruning learned of her diagnosis of Generalized Myasthenia Gravis or gMG in May of 2021.

For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety ...

New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...

Guillain-Barre Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks the ...

Abby Smith, 40, a NHS manager from Reading, has the rare autoimmune disease myasthenia gravis, which means she needs her ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

Physicians received unexpected news recently when a small study published in JAMA Network Open found that ChatGPT-4 had outdone us at our own craft: diagnosis, what some have called the physician ...

her 15-item Myasthenia Gravis Quality of Life (MGQOL-15) and MG-associated Activities of Daily Living (MG-ADL) scores were 20 and 15, respectively, reflecting a considerable impact on her quality of ...